Reflecting on OCT Europe

VCTC Shares Insights from OCT Europe Conference

After attending the OCT Europe conference a couple of weeks ago, the VCTC team has reflected on several key takeaways that emerged from the discussions.

A major focus of the conference was the importance of site involvement in the design of trial protocols and operations. Engaging sites in this process can lead to numerous benefits, including more realistic and feasible protocols. Since sites have direct interaction with patients, they better understand their concerns and needs. This collaboration can streamline processes, leading to faster study start-up times and more efficient trial operations that are ultimately cost-effective.

Sponsors are also exploring innovative ways to engage trial-naïve sites to broaden the pool of available high-quality locations. This includes considering sites with no prior research experience or those looking to expand into additional therapeutic areas.

These insights emphasize the significance of collaboration and innovation in enhancing clinical trial design and operations, ultimately improving patient outcomes.